Sanofi
Sanofi is a global life sciences company, focused on patient’s needs. Interactions with this account must comply with the Terms.
Last synced from Twitter Not synced yet
Sanofi: Press Releases, Wednesday, October 28, 2020
https://www.sanofi.com/en/media-room/press-releases/2020/2020-10-28-07-00-00 128d 2 tweets
Read the latest news about our company
1
Sanofi Sanofi and have signed a Statement of Intent with the #COVAX facility to secure the distribution of our #COVID19 vaccine worldwide: #SanofiActs 128d
Sanofi: Press Releases, Tuesday, October 13, 2020
https://www.sanofi.com/en/media-room/press-releases/2020/2020-10-13-07-00-00 143d 1 tweets
Read the latest news about our company
1
Sanofi With , we’re announcing positive topline results in a pivotal trial in children aged 6-11 years with uncontrolled #asthma. Read more: 143d
‘Agents of Change’ Atopic Dermatitis Challenge: Navigating Uncertainty
Openideo.com 172d 2 tweets
How might we help people living with atopic dermatitis and those around them navigate the daily uncertainty of their condition, including its unpredictable and often severe symptoms?
1
Sanofi In recognition of World Atopic Dermatitis Day, we’re excited to announce the 2020 ‘Agents of Change’ AD Challenge with . Learn more about this year’s challenge and how you can participate here . 172d
1
Sanofi With , we want to help people like Lidia better navigate the daily uncertainty of their #AtopicDermatitis (AD). Submit your idea for the 2020 ‘Agents of Change’ AD Challenge today at . 158d
Live interview with Paul Hudson, CEO Sanofi | LinkedIn
Linkedin.com 175d 1 tweets
Join us for our live interview with Sanofi CEO Paul Hudson. The boss of the French multinational pharmaceutical company will be talking about the coronavirus vaccine, reshoring production and the pandemic's impact on his company. If you have...
1
Sanofi On Tuesday September 15, our CEO Paul Hudson will be participating in a LinkedIn Live session to discuss #COVID19 vaccines, healthcare sovereignty, and the impact of the pandemic on the company. Register here: 175d
Starting the Countdown to Better Asthma Control
Sanofi.com 182d 1 tweets
The average person takes 8.4 million breaths every year. For people living with severe asthma, that can be 8.4 million moments of worry. What will my next breath bring? How will it impact my life?
1
Sanofi Learn about our efforts to increase #asthma awareness and support the patient community in taking steps toward better asthma control. 182d
‘Agents of Change’ AD Challenge
Changead.com 212d 2 tweets
The 'Agents of Change' AD Challenge is a new global grants-initiative, seeking proposals to support grassroot solutions to help solve some of the greatest challenges impacting those living with atopic dermatitis.
1
Sanofi We can't wait to see the 2019 ‘Agents of Change’ AD Challenge grant recipients help make a difference in the #AtopicDermatitis community. Learn more about the challenge at 212d
1
Sanofi We were impressed by the 2019 ‘Agents of Change’ AD Challenge proposals that aim to combat bullying in the #AtopicDermatitis community. Check out the grant recipients and learn more about the initiative at . 211d
One Face, One Journey
Sanofi.com 253d 1 tweets
Sanofi is committed for Pride 2020
1
Sanofi #Pride2020 Before coming out, Emmanuel Desproges, IT leader Australia, New Zealand and South Korea, wore a mask to work every day: "I wasn’t pretending to be straight, just trying to be as invisible as possible." Check to watch all our employees' stories. 253d
Sanofi: Press Releases, Friday, June 19, 2020
https://www.sanofi.com/en/media-room/press-releases/2020/2020-06-19-13-30-00 259d 1 tweets
Read the latest news about our company
1
Sanofi Our medicine is now approved in China for the treatment of moderate-to-severe #atopicdermatitis in adults whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. cc Read the news: 259d
Harnessing the Power Of The Asthma Experience
home 260d 2 tweets
Learn how the research community taps into the asthma experience of those who know it best – people with asthma – and how these insights help advance care.
1
Sanofi In our new blog post on The Next Breath, we hear from our own Dr. Paul Rowe and ’s Dr. Yamo Deniz about the importance of patients getting involved in research to advocate for their care. Check out the full interview. 260d
Change AD
Changead.com 261d 1 tweets
Finding better ways to manage your AD in the long term can mean you can focus on making up for lost time.
1
Sanofi #AtopicDermatitis (AD) can place a burden on the entire family, especially parents and caregivers. With , we are here to educate about the impacts of this chronic skin disease and to #ChangeAD. Visit to learn more. 261d
The Different Faces of Type 2 Inflammation: Amit and Tzippy’s Stories
Sanofi.com 268d 1 tweets
On the surface, atopic dermatitis (AD), a chronic skin condition, and asthma, a respiratory disease, may not appear to have much in common, but beneath the surface, both are driven by an immune response called type 2 inflammation.
1
Sanofi While Amit and Tzippy live with different type 2 inflammatory diseases, they have experienced many of the same emotional burdens. Watch them tell their stories. 268d
Sanofi: Press Releases, Monday, June 8, 2020
https://www.sanofi.com/en/media-room/press-releases/2020/2020-06-08-07-00-00 270d 1 tweets
Read the latest news about our company
1
Sanofi At our upcoming scientific session on 6/16, we will present Phase 3 results of our investigational therapy in late-onset #Pompe disease. Find out more: 270d
Sanofi: Press Releases, Saturday, May 23, 2020
https://www.sanofi.com/en/media-room/press-releases/2020/2020-05-23-00-25-00 286d 2 tweets
Read the latest news about our company
1
Sanofi #Sanofi and announce positive results from our trial in adults and adolescents with #EosinophilicEsophagitis. 286d
COVID-19: Patient Resource Center
Sanofi.com 304d 2 tweets
COVID-19: Patient Resource Center
1
Sanofi #SanofiActs We are committed to supporting the #asthma community in these times of uncertainty–and beyond. Our Patient Resource Center provides links to trusted resources to help people with asthma protect themselves and manage their disease. Learn more: 304d
Sanofi: Press Releases, Tuesday, April 14, 2020
https://www.sanofi.com/en/media-room/press-releases/2020/2020-04-14-13-00-00 325d 1 tweets
Read the latest news about our company
1
Sanofi #SanofiActs against #COVID19 Sanofi joins forces with , a fellow leader in vaccines, to develop an adjuvanted vaccine for #coronavirus, using innovative technology from both companies. Read more here: 325d
Sanofi: Press Releases, Friday, April 10, 2020
https://www.sanofi.com/en/media-room/press-releases/2020/2020-04-10-07-55-20 329d 2 tweets
Read the latest news about our company
2
Sanofi #SanofiActs To #FightCOVID19, Sanofi will donate 100 million doses of #hydroxychloroquine across 50 countries. Read the news 329d
Life Science Companies Commit to the Fight Against COVID-19 Pandemic alongside Gates Foundation
Gatesfoundation.org 344d 5 tweets
1
Sanofi We’re proud to be part of the consortium to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments to fight #COVID19. Learn more 344d
Newsday - 20/03/2020 07:06 GMT - BBC Sounds
BBC Sounds - BBC 350d 1 tweets
Live news, business and sport from around the world.
1
Sanofi As #COVID19 spreads, our CEO Paul Hudson shared Sanofi's total commitment to the fight against the virus on . Hear the full interview: 350d
Doing our part in times of crisis
Linkedin.com 353d 2 tweets
The world is grappling with a pandemic. People across the globe fear the impact on the health of individuals and communities, and the global economy is shaking.
1
Sanofi "As #COVID19 continues to spread, it is our job in the healthcare industry to do our part, which includes not only developing vaccines and treatments, but also keeping the public informed" Hear from Paul Hudson, our CEO, who shares Sanofi's commitment 353d
Sanofi and Regeneron begin global Kevzara® (sarilumab) clinical trial program in patients with severe COVID-19 - Mar 16, 2020
News.sanofi.us 354d 2 tweets
2
Sanofi We initiated a global clinical program with for people hospitalized with severe #COVID19, testing the IL-6 receptor antibody. Read on 354d